Aeolus Pharmaceuticals, Inc. Stock OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2015 | 3.11M 4.25M | Sales 2016 | 2.08M 2.83M | Capitalization | 28.9M 39.44M |
---|---|---|---|---|---|
Net income 2015 | -2M -2.73M | Net income 2016 | -3M -4.09M | EV / Sales 2015 | 10.8 x |
Net Debt 2015 | 908K 1.24M | Net cash position 2016 | 3.16M 4.31M | EV / Sales 2016 | 12.4 x |
P/E ratio 2015 |
-12
x | P/E ratio 2016 |
-4.67
x | Employees | - |
Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
John McManus
CEO | Chief Executive Officer | 60 | 05-05-31 |
David Cavalier
CHM | Chairman | 54 | 04-04-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Cavalier
CHM | Chairman | 54 | 04-04-29 |
Jeffrey Scott
BRD | Director/Board Member | 67 | 13-05-07 |
John Clerici
BRD | Director/Board Member | 54 | 13-05-07 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |